Ultralife Corporation
ULBI
$6.67
$0.010.15%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 5.38M | 6.41M | 8.96M | 10.03M | 10.40M |
| Total Depreciation and Amortization | 4.54M | 4.16M | 3.94M | 3.94M | 3.91M |
| Total Amortization of Deferred Charges | 140.00K | 91.00K | 60.00K | 64.00K | 64.00K |
| Total Other Non-Cash Items | 1.85M | 2.09M | 2.01M | 2.38M | 2.89M |
| Change in Net Operating Assets | 8.17M | 3.89M | 1.05M | -6.03M | -14.06M |
| Cash from Operations | 20.09M | 16.64M | 16.02M | 10.39M | 3.21M |
| Capital Expenditure | -2.46M | -1.93M | -2.33M | -2.27M | -2.43M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -48.02M | -48.02M | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -50.48M | -49.95M | -2.33M | -2.27M | -2.43M |
| Total Debt Issued | 55.00M | 55.00M | 1.00M | 2.95M | 4.95M |
| Total Debt Repaid | -25.93M | -25.75M | -19.21M | -15.68M | -3.00M |
| Issuance of Common Stock | 1.31M | 2.00M | 2.17M | 3.12M | 1.93M |
| Repurchase of Common Stock | -- | -- | -8.00K | -8.00K | -8.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.39M | -1.39M | -68.00K | -- | -- |
| Cash from Financing | 28.99M | 29.86M | -16.12M | -9.62M | 3.88M |
| Foreign Exchange rate Adjustments | 24.00K | 34.00K | -97.00K | -94.00K | -167.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.38M | -3.42M | -2.53M | -1.59M | 4.49M |